Objectives: To evaluate the efficacy of the Crane reduction technique in midline lumbar fusion (MIDLF) with cortical bone trajectory screws for treating degenerative spondylolisthesis, and to identify factors affecting the reduction rate.
Methods: A retrospective analysis was conducted on 87 patients (64 female and 23 male) with L4-5 degenerative spondylolisthesis who underwent MIDLF and the Crane technique. Patients were categorizing using the spondylolisthesis Meyerding classification system into Grade I (59 patients) and Grade II (28 patients) groups and compared for demographics, radiographic parameters, and the spondylolisthesis reduction rate. Data were analyzed to identify factors influencing the reduction rate.
Results: Grade II patients showed higher preoperative spondylolisthesis slip ratio (SR) (29.8 ± 3.7% vs. 19.9 ± 3.2%, p < 0.01) and a lower segmental lordosis (SL) than Grade I patients. Postoperatively, Grade II patients achieved higher reduction rates (92.6% [90.8-93.8] vs. 89.9% [86.8-91.4] in Grade I, p < 0.01) and a greater SL increase (+2.4° [-0.2-5.5] vs. -1.2° [-3.5-1.6], p < 0.01). Multivariable analysis revealed vacuum disc phenomenon had a negative impact (β = -0.070, p < 0.01) and SR had a positive impact (β = 0.612, p < 0.01) on the slip reduction rate. Complications occurred in 4.6% of cases, including three intraoperative durotomy and one nut loosening requiring revision surgery.
Conclusions: The Crane technique combined with MIDLF is an effective and safe surgical approach for treating L4-5 degenerative spondylolisthesis, demonstrating high reduction rates with consistent minimal residual slip, particularly in Grade II cases.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.wneu.2025.123664 | DOI Listing |
S Afr J Surg
December 2024
Department of Surgery, Tygerberg Hospital, Stellenbosch University, South Africa.
Background: COVID-19 was first identified in Wuhan, China, in December 2019, where it spread over a wide geographic area until it reached the status of a pandemic in 2020. We postulated that patients who were diagnosed with incidental COVID-19, and underwent surgery, did not have a worse outcome due to the COVID-19 virus compared to their counterparts who did not have the virus.
Methods: This retrospective study included surgical patients (COVID-19 incidentals and COVID-19 negatives) who were admitted to the surgical intensive care unit (SICU) at Tygerberg Academic Hospital between 1 May 2020 and 31 December 2021.
Am J Surg Pathol
January 2025
Department of Pathology.
Despite being designated as "noncarcinogenic" human papillomavirus (HPV) types, mono-infection with HPV6 or HPV11 has been found in squamous cell carcinomas (SCCs) at specific sites, including the larynx, penis, anus, and rarely, the lower female genital tract. The association between clinicopathologic features, viral status, and the carcinogenic mechanisms related to these low-risk HPVs remains unclear. The current study characterizes a series of low-risk HPV6 and HPV11-associated SCCs of the uterine cervix (6 cases) and vulva (2 cases).
View Article and Find Full Text PDFFront Oncol
January 2025
Sorbonne University and Saint-Antoine Hospital, APHP, Paris, France.
Background: Trifluridine/tipiracil (FTD/TPI) is approved as monotherapy and in combination with bevacizumab for the treatment of patients with refractory metastatic colorectal cancer (mCRC). FTD/TPI plus bevacizumab showed good tolerability in the phase 3 SOLSTICE (first-line) and SUNLIGHT (later-line) trials. This pooled analysis was performed to further characterize the safety of FTD/TPI plus bevacizumab and to compare safety in untreated and previously treated patients with mCRC.
View Article and Find Full Text PDFFront Oncol
January 2025
Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Objective: To investigate the optimal cut-off value of immunohistochemical marker Ki67 as a prognostic factor to predict the recurrence of non-muscle invasive bladder urothelial carcinoma (NMIBUC).
Methods: A total of 331 patients diagnosed with NMIBUC who underwent surgery in the Yongchuan Hospital and the Second Affiliated Hospital of Chongqing Medical University from January 2012 to January 2020 were finally included in this study. The optimal cut-off value of Ki67 for predicting recurrence of NMIBUC was calculated by ROC curve and Youden index.
Front Oncol
January 2025
Department of Pancreatic and Gastric Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Background: Mucin family members have been reported to be widely expressed in gastric carcinoma with diverse functions. Several important mucins exert the function of tumorigenesis or progression in gastric cancer (GC). Here, we conduct this meta-analysis to evaluate the association between mucin expression and clinicopathological features in GC.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!